The latest gastro-intestinal cancer news
Screening and removal of precancerous lesions prevents anal cancer
In a groundbreaking finding, a new study led by UC San Francisco found that routine…
Browsing: GI Cancers
Colon cancer cell growth may be inhibited by cannabinoids
Colorectal cancer is the third leading cause of cancer mortality in the U.S. The American Cancer…
Every single patient in this small experimental drug trial saw their cancer disappear
In what appears to be a very promising breakthrough for the treatment of rectal cancer, a…
Bowel cancer screening test won’t save your life in the drawer
With bowel cancer expected to claim the life of more than 1,800 people in NSW…
The OJC 66: ASCO 2022 GI ctDNA Special with Jeanne Tie
Today’s episode of The Oncology Journal Club podcast series is an ASCO 2022 Special… Craig…
DNA shed from colon cancers into bloodstream successfully guides chemotherapy after surgery
A new research study showed that circulating tumour DNA (ctDNA)—genetic material shed from tumours into…
Aussies urged to take a half-time toilet break for bowel cancer this State of Origin series
With the NRL State of Origin set to kick off in Sydney, Australians are being…
ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein
A drug combination targeting multiple mutant versions of cancer’s ‘death star’ protein has shown promise…
ASCO 2022: ctDNA may help identify the need for adjuvant therapy in stage II colon cancer
In patients with stage II colon cancer where cancer DNA was not present in the…
ASCO 2022: Combination regimen improves overall survival in a type of newly diagnosed metastatic colorectal cancer
The use of panitumumab (Vectibix) plus mFOLFOX6 significantly improved overall survival in patients with RAS wild-type metastatic…